5/2
Penn in the News
A round-up of Penn mentions in local, national, and international media.
Filter Stories
Penn In the News
Thanks to the pandemic, we now also have ‘an epidemic of sleep deprivation’
Michael Perlis of the Perelman School of Medicine said it’s normal for sleep to suffer under stressful circumstances, such as a pandemic. “Evolution or God programmed us not to sleep when there’s a perceived threat,” he said. “If you have a lion looking at you and licking its lips, you shouldn’t go to sleep.”
Penn In the News
Column: Walmart’s low-priced insulin shows what a rational drug market should look like
Mark V. Pauly of the Wharton School weighed in on Walmart’s new, lower cost insulin. The offering “may be a PR or traffic-building exercise,” he said, but could ultimately pressure drug companies to lower their prices.
Penn In the News
Why storytelling is an important tool for social change
Emily Falk of the Annenberg School for Communication explained the neuroscience behind how the brain processes and learns from stories. “Storytelling alone, of course, can’t produce structural changes in the justice system or create better policies aimed at health, the environment and other issues that affect our well-being,” she wrote. “But that said, changing systems large or small has to start with effective communication.”
Penn In the News
What’s size got to do with it? Mocking a man’s manhood spurs a reverse #MeToo in South Korea
Jinsook Kim, a postdoc in the Annenberg School for Communication, spoke about the backlash against feminist activism in South Korea. “The younger generation suffers from frustration and economic precarity,” Kim said. “The problem is, these young Korean men, they ascribe their sense of victimhood or precarity not to government or policies but to women who they see as preventing them from receiving their due.”
Penn In the News
Column: High cost of hearing aids shows (yet again) the insanity of medical pricing
Matthew Grennan of the Wharton School spoke about the high cost of hearing aids. “Medical devices are this weird class of goods where the manufacturing cost is relatively low, but the value they create is high,” he said.
Penn In the News
Black, Latinx and female entrepreneurs are still ignored by most venture capitalists
Katherine Klein of the Wharton School spoke about the lack of diversity in venture capital funding. “The disparity in who the venture capitalists are and where their money goes is just phenomenal,” she said.
Penn In the News
Column: How the Church of Scientology hopes to quash a lawsuit by Danny Masterson’s accusers
Marci Hamilton of the School of Arts & Sciences spoke about a civil lawsuit filed against Danny Masterson, the Church of Scientology, and its leader, saying she was worried that litigants would be forced into arbitration because of agreements they’d signed when joining the church.
Penn In the News
High school revisited: Students reflect on their year away from campus
Kaitlyn Nguyen, a high school senior in Pomona, California, spoke about being accepted to Penn as an early decision applicant. “I came to the realization that this was the school for me,” she said. “I came to this conclusion primarily because of Penn’s commitment to community service and community advocacy work, which has been something that I have been passionate about growing up.”
Penn In the News
Landlords are waiting for rent payments—and some can’t hold on much longer
A survey conducted by Vincent Reina of the Stuart Weitzman School of Design found that property owners are dealing with late rent payments and trouble filling vacancies amid the pandemic, challenging their ability to pay mortgages, property taxes, and maintenance expenses.
Penn In the News
This L.A. start-up is building tiny injectable robots to attack tumors
Marc Miskin of the School of Engineering and Applied Science commented on a new startup that is developing remote-control medical microrobots. “I would give them a lot of credit for figuring out a space where they can make an impact and justify how they’ll be competitive with traditional pharmaceutical approaches,” he said.